Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 4 results for "olopatadine"

For allergy symptoms, steroid sprays may be your best option
Washington Post

For allergy symptoms, steroid sprays may be your best option

By Consumer Reports, Should you use Flonase or Nasacort for your allergies? Both are good options. Research suggests that nasal steroid sprays such as fluticasone (Flonase Allergy Relief) and triamcinolone (Nasacort Allergy 24HR) are the ... Washington Post, 2 weeks ago

WARNING! Don't use unregistered eye drops for sore eyes The online news portal of TV5 MANILA - A health watchdog cautioned the public against using eye drops that are not registered with the Food and Drugs Administration (FDA). In a news release, the EcoWaste Coalition sounded the ...
 Interaksyon1 month ago
Ophthalmology Management

Tis the season to be red-eyed

It's prime allergy season: Here's a primer on what to advise patients with an itch to ditch. By Mark B. Abelson, MD O ptions for treating allergic conjunctivitis are abundant, and both ophthalmologist and patient could use guidance in selecting ...
 Ophthalmology Management1 month ago

Ophthalmic drug delivery

The present invention includes and provides a method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising: (a) providing droplets containing the medicament with a specified average size and average ...
 PharmCast2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less